Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Len Schleifer
Pharma
Without equity awards, Regeneron's Schleifer made $7M in 2022
Regeneron CEO Len Schleifer collected $7M in 2022, while chief scientific officer George Yancopoulos pulled down $6.6M, according to an SEC filing.
Kevin Dunleavy
Apr 24, 2023 10:32am
Legendary Regeneron chairman Roy Vagelos to retire at age 93
Apr 17, 2023 10:34am
FDA approves Regeneron's Eylea for retinopathy of prematurity
Feb 9, 2023 11:18am
Regeneron looks forward to launch of longer-lasting Eylea
Feb 3, 2023 12:38pm
Eylea sales disappoint in Q4, Regeneron says its a 'blip'
Jan 9, 2023 3:15pm
With $453M, Regeneron's Schleifer tops biopharma's realized pay
Jul 18, 2022 11:17am
